{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T12:43:48Z","timestamp":1695473028657},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/inf.0b013e31828d6b20","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T21:56:44Z","timestamp":1363989404000},"page":"777-785","source":"Crossref","is-referenced-by-count":7,"title":["A Randomized, Controlled Trial to Assess the Immunogenicity and Safety of a Heptavalent Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Hib and Meningococcal Serogroup C Combination Vaccine Administered at 2, 3, 4 and 12\u201318 Months of Age"],"prefix":"10.1097","volume":"32","author":[{"given":"Leszek","family":"Szenborn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Czajka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Brzostek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryszard","family":"Konior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magalie","family":"Caubet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Ulianov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"Leyssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-22-20210202","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.inf.0000222413.47344.23","article-title":"The use of combination vaccines has improved timeliness of vaccination in children.","volume":"25","author":"Kalies","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R4-22-20210202","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/INF.0b013e31805d7f17","article-title":"Use of combination vaccines is associated with improved coverage rates.","volume":"26","author":"Marshall","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R5-22-20210202","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/11204830-000000000-00000","article-title":"DTPa-HBV-IPVHib vaccine (Infanrix hexa): A review of its use as primary and booster vaccination.","volume":"70","author":"Dhillon","year":"2010","journal-title":"Drugs"},{"key":"R6-22-20210202","doi-asserted-by":"crossref","first-page":"e1103","DOI":"10.1542\/peds.2008-3422","article-title":"Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.","volume":"123","author":"Pavia","year":"2009","journal-title":"Pediatrics"},{"key":"R7-22-20210202","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1440-1754.2007.01139.x","article-title":"DTPa-HBV-IPV vaccine for primary vaccination of infants.","volume":"43","author":"Nolan","year":"2007","journal-title":"J Paediatr Child Health"},{"key":"R8-22-20210202","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.inf.0000148923.46453.48","article-title":"Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate vaccine.","volume":"24","author":"Tichmann-Schumann","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R9-22-20210202","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1586\/erv.09.113","article-title":"10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.","volume":"8","author":"Prymula","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"R10-22-20210202","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/14760584.8.3.265","article-title":"Prevention of meningococcal serogroup C disease by NeisVac-C.","volume":"8","author":"Borrow","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"R11-22-20210202","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R12-22-20210202","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"R13-22-20210202","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection-serum bactericidal antibody activity.","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"R14-22-20210202","first-page":"149","article-title":"Serologic response to serogroup C meningococcal vaccine in Brazilian preschool children.","volume":"16","author":"Amato Neto","year":"1974","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"R15-22-20210202","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies.","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"R16-22-20210202","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1542\/peds.60.5.730","article-title":"Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.","volume":"60","author":"Peltola","year":"1977","journal-title":"Pediatrics"},{"key":"R17-22-20210202","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/149.6.1034","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.","volume":"149","author":"Anderson","year":"1984","journal-title":"J Infect Dis"},{"key":"R18-22-20210202","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.","volume":"147","author":"Kayhty","year":"1983","journal-title":"J Infect Dis"},{"key":"R19-22-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-1157(83)80038-9","article-title":"A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera.","volume":"11","author":"Melville-Smith","year":"1983","journal-title":"JBiol Stand"},{"key":"R20-22-20210202","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/JCM.20.4.772-774.1984","article-title":"Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum.","volume":"20","author":"Camargo","year":"1984","journal-title":"J Clin Microbiol"},{"key":"R21-22-20210202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF02097184","article-title":"Acellular pertussis vaccine in adults: adverse reactions and immune response.","volume":"6","author":"Granstrom","year":"1987","journal-title":"Eur J Clin Microbiol"},{"key":"R22-22-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-1759(87)90289-4","article-title":"Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA).","volume":"103","author":"Karpinski","year":"1987","journal-title":"J Immunol Methods"},{"key":"R23-22-20210202","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/CVI.13.3.356-360.2006","article-title":"Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera.","volume":"13","author":"Henckaerts","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R24-22-20210202","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/INF.0b013e31813429fa","article-title":"A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.","volume":"26","author":"Pace","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R25-22-20210202","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/adc.2007.136036","article-title":"A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.","volume":"93","author":"Pace","year":"2008","journal-title":"Arch Dis Child"},{"key":"R26-22-20210202","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/CVI.00377-06","article-title":"Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine.","volume":"14","author":"Schmitt","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"R27-22-20210202","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/INF.0b013e3181fcb2bf","article-title":"Immunogenicity and safety of an investigational combined haemophilus influenzae type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine.","volume":"30","author":"Nolan","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R28-22-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.inf.0000247070.60063.09","article-title":"Spanish DTPa-HBV-IPV-097 Study Group. Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae Type b and Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine coadministered with a Diphtheria-tetanus-acellular Pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months.","volume":"26","author":"Tejedor","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R29-22-20210202","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/erv.09.32","article-title":"Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPVHib hexavalent vaccine).","volume":"8","author":"Zepp","year":"2009","journal-title":"Expert Rev Vaccines"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e31828d6b20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T05:34:20Z","timestamp":1644644060000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201307000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31828d6b20","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}